Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Director/PDMR Shareholding

ZIGUP plc ("ZIGUP" or the "Company") NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS This announcement is made in accordance with Article 19 of the Market Abuse Regulation ('MAR'). The Company announces that the nil cost award of options over ordinary shares of £0.50 pence each in the Company made to Jorge Alarcon Alejandre under the Company’s 2019 Executive Performance Share Plan vested on 27 March 2020 and 9 August 2024 respectively. On 30 August 2024, the PDMR exercised the following Awards and sold the following

Swedavia’s traffic statistics for August 2024: Increased air traffic and new conditions for sustainable aviation

Air travel at Swedavia's ten airports increased by two per cent compared with August 2023. The increase was driven by continued strong international travel, which increased by five per cent, while domestic travel decreased by nine per cent. In August, international travel at Stockholm Arlanda Airport increased by five per cent and increased by four per cent at Göteborg Landvetter Airport.“Demand for international travel at Arlanda and Landvetter continued to be strong in August. During this year's summer traffic programme, a total of 25 new routes were launched, of which 17 were new routes

Salsa Technology Announces Thiago Valadao as Country Manager for Brazil

Salsa Technology today announced a significant addition to its commercial team with the arrival of business specialist Thiago Valadão, who will take on the role of Country Manager for Brazil.With extensive experience in management positions in the technology industry, Valadão joins to amplify Salsa’s position as the leading technology provider for the regulated iGaming and Sports Betting market in the country. “Salsa has been preparing for a long time to become the best technology partner for the regulated Brazilian market, and being able to count on Valadão’s professional experience to

BC.GAME Partners with Multi-Platinum Artist Jason Derulo

BC.GAME, a pioneering online gaming platform in the cryptocurrency space, is thrilled to announce a landmark partnership with multi-platinum award-winning artist Jason Derulo. This exclusive collaboration marks a significant milestone for BC.GAME as it continues to redefine the boundaries of entertainment in the gaming industry. The partnership will unfold throughout 2024, featuring a dynamic blend of live events, unique content, and unparalleled fan interactions designed to captivate and engage BC.GAME’s global community.This exciting development comes on the heels of BC.GAME’s recent

Nynas circular transformer oil achieves certification

Offering a fully circular transformer oil significantly enhances resource efficiency in the electrical industry. The solution provided by Nynas in collaboration with Stena has now been awarded a quality mark in the form of ISCC Plus certification.Since 2023, Stena Recycling has supplied Nynas with used oil from transformers. Stena collects discarded transformer oil via a European network, pre-treats it, and then delivers it to Nynas, where the oil is used as a raw material for the production of re-refined transformer oil. This circular solution has now also earned ISCC Plus certification.

SyntheticMR Announces the Appointment of Francois Hebert as New President, North America

SyntheticMR is thrilled to announce the appointment of Francois Hebert as the new President of SyntheticMR, North America. With three decades of experience in healthcare and medical imaging, Frank brings extensive expertise from his recent senior leadership roles."I am thrilled to join SyntheticMR, a company at the forefront of medical imaging innovation. My focus will be on accelerating our mission to transform patient care through our unique technology and provide radiologists with decision support solutions and essential quantitative data, with the goal of making SyMRI the standard of

ITAB awarded MEUR 20 contract for roll out of new shop-in-shop concept in European reseller network

ITAB Group has signed a framework agreement with a world leading manufacturer of window coverings for the roll out of a new shop-in-shop concept in some 900 stores in their reseller network throughout Europe. Although there are no minimum commitments, the implementation is currently underway, and the total value of the contract is estimated to be at least MEUR 20 over four years.A leading manufacturer of window coverings has chosen ITAB Group as their partner for the roll out of a new shop-in-shop concept in some 900 home improvement retailers in their reseller network. Under the framework

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2024

Zinzino group revenue increased with a total of 39 %, compared with the previous year. The revenue in August for Zinzino's sales markets increased by 38 % and amounted to SEK 166.4 (120.6) million. Faun Pharma's external sales increased by 58 % and amounted to SEK 12.3 (7.8) million. Overall, the Group increased revenues by 39 % to SEK 178.7 (128.4) million compared with the previous year. Accumulated revenue for January – August 2024 increased by 21 % to SEK 1309.4 (1080.3) million. Revenues were distributed as follows: Regions,MSEK 24 23 Change YTD YTD

New preclinical data for Cereno Scientific’s novel IP Receptor Agonist CS585 presented at ESC Congress 2024

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced new preclinical data indicating that drug candidate CS585, a novel prostacyclin (IP) receptor agonist, inhibits platelet activation and clot formation up to 24 hours post-administration. The new data was presented at the ESC (European Society of Cardiology) Congress 2024, on August 30–September 2, 2024.CS585, was shown to inhibit platelet activation and clot formation in the blood up to 24 hours post administration. In both in vivo

BiBB receives an Intention to Grant for EndoDrill patent in Europe

The cancer diagnostics company BiBBInstruments AB ("BiBB"), the developer of the world's first market-cleared electric-driven biopsy instrument for endoscopy, today announces that the Company has received an Intention to Grant from the European Patent Office (EPO). The notice means that the EPO intends to approve a divisional patent application (first patent family) in Europe for EndoDrill[®]. Certain formalities will now follow before approval, after which the patent will be valid until October 2039.BIBB has received an Intention to Grant from the EPO regarding the approval of the patent

GF Piping Systems Appoints W&O as Maritime Partner for Marine Markets in Europe, USA, and Asia

GF Piping Systems, the leading manufacturer of plastic piping systems, is pleased to announce the appointment of W&O as its Maritime Partner for marine markets across Europe, the USA, and Asia. This strategic partnership will enhance the availability of GF Piping Systems' products at key supply hubs operated by W&O in these regions.Under the terms of the agreement, W&O, a recognized leader in supplying valves, actuation, piping systems, and instrumentation to the global maritime industry, will significantly expand its inventory of GF Piping Systems' products. This increased stock will

The Board of Directors resolves on a directed issue of units and preferential rights issue of units

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE THIS PRESS RELEASE IS DISTRIBUTABLE WOULD BE ILLEGAL OR REQUIRE ADDITIONAL ACTIONS THAN SUCH ACTIONS RESULTING FROM DANISH LAW. SEE THE “IMPORTANT INFORMATION” SECTION AT THE END OF THIS PRESS RELEASE. Copenhagen, Denmark, 4 September 2024 – Curasight A/S ("Curasight" or the “Company" – TICKER: CURAS) today announces that the Board of Directors

RMD Develops Mount for Display Screens on Remote Control Units

At RMDs partner Brodit in Karlsborg, development is currently underway on an accessory in the form of a mount for the display screens of rearview cameras. The adapter with its mount is easily attached to the remote control used for switching and backing up trains.Switching out a train and rearranging its wagons at a terminal involves a lot of work. What used to be managed by a train driver and a signaler at the back of the train can now be handled by the driver alone, thanks to RMDs rearview camera. The rearview camera provides the train driver with visibility in the direction of travel

DecideAct A/S - registration of share capital increase of 654,543 new shares with the Danish Business Authority completed

DecideAct A/S [ACT], company announcement no. 8-2024: In connection with the directed issue that was announced on 28 August 2024, the Board of Directors of DecideAct A/S (the Company) hereby announces that the Company has registered the capital increase of a nominal value of DKK 65,454.30 (654,543 shares of DKK 0.10 each) with the Danish Business Authority following the directed issue that was published on 28 August 2024. Reference is made to company announcement no. 5/2024.The new shares are identical to the Company’s existing shares and an application will be made for them to be

Director/PDMR Shareholdings

Capital for Colleagues plc / EPIC: CFCP / Market: Aquis / Sector: Financials   4 September 2024 CAPITAL FOR COLLEAGUES PLC (‘Capital for Colleagues’, ‘C4C’ or the ‘Company’)   DIRECTOR/PDMR SHAREHOLDINGS   Capital for Colleagues, the investment vehicle focused on opportunities in the Employee Owned Business (‘EOB’) sector, has been notified that C4C SIP Trustee Limited (the ‘Trustee’) has allocated a total of 20,875 existing ordinary shares of 40p each in the Company (‘Ordinary Shares’) to participants in the Company’s Share Incentive Plan (‘SIP’) at a price of 60p

Information on divestment of shares in Logistea by Slättö’s funds

Slättö has today divested all its funds’ holdings in Logistea AB (publ) (“Logistea”) to M2 Asset Management AB (publ) at a price of SEK 16.00 per share. The shares in Logistea were owned through Slättö’s funds and correspond to 10.12% and 11.25% of Logistea’s outstanding shares and votes respectively.Erik Dansbo, Senior Partner and Chief Investment Officer at Slättö, says: "We have successfully carried out our business plan and have supported Logistea in its transformation from a Swedish company with a market cap of SEK 1.5 billion to a Nordic company with a market cap of almost SEK 8

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology

· 21st.BIO has earned a self-affirmed GRAS status for its animal-free beta-lactoglobulin ingredient, which customers can now launch in the United States market. · 21st.BIO is helping customers bring products to market at an unprecedented pace, from initiation of development to market approval in under two years. · 21st.BIO offers the leading production technology for BLG, based on precision fermentation technology that has been perfected over decades and partly licensed from Novonesis (formerly Novozymes). · By studying the variation in cows’ milk protein, 21st.BIO’s world class

Epiroc to expand rock drilling tools manufacturing facility, opens innovation center in Hyderabad, India

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and construction industries, today is holding a ground-breaking ceremony in Hyderabad, India, for an expansion of its manufacturing facility for rock drilling tools. Epiroc is also today inaugurating a new innovation and technology center in Hyderabad. The investment is part of Epiroc’s growing focus on India as a key hub for manufacturing and research and development to support customers throughout the region.Epiroc’s investment covers expansion of land, new buildings, and state-of-the-art machines.

atNorth Announces Heat Reuse Enabled Mega Data Center in Denmark

With an initial capacity of 250MW the site will have a path to power of several hundred MW, implementing heat reuse to heat large scale greenhouses, local housing and opportunities for sustainable power production.Copenhagen, Denmark – September 4[th], 2024 –  atNorth , the leading Nordic colocation, high-performance computing, and artificial intelligence service provider, has announced plans to build its largest data center to date in the town of Ølgod in Varde Denmark. The site, to be known as DEN02, will cater to both colocation and build-to-suit projects and will

Heart Aerospace and Loganair enter Exclusive Partnership to Advance Hybrid-Electric Aviation in the UK

Heart Aerospace, the Swedish hybrid-electric airplane maker, and Loganair, the UK-based regional airline, are pleased to announce a new and exclusive partnership aimed at decarbonizing regional air travel in the United Kingdom.As part of the agreement, Loganair and Heart Aerospace will exclusively collaborate on establishing use-cases for hybrid electric aircraft within Loganair’s extensive Scottish and UK network. Loganair, headquartered at Glasgow Airport, primarily operates domestic flights within the UK where it is the largest regional airline by passenger numbers and fleet size. At

Zalaris announces participation at UNLEASH World 2024

Zalaris, a leading provider of HR and payroll solutions, is thrilled to announce its participation in UNLEASH World 2024, a premier conference and exhibition for HR professionals worldwide.The event will take place on October 16-17, 2024, at Hall 7.3, Paris Expo Porte de Versailles.  UNLEASH World 2024  gathers top HR leaders, innovators, and experts from across the globe to explore the latest advancements and trends shaping the future of work. Attendees will have the opportunity to discover breakthrough technologies, engage in thought-provoking

Nokian Tyres has signed a development agreement aiming to add renewable material made from residue birch bark to tires

Nokian Tyres plc Press Release September 4, 2024 at 10:00 a.m. EEST Nokian Tyres has signed a development agreement with a Swedish biomaterial science company Reselo AB to further develop their renewable material Reselo Rubber as a potential new raw material in tires. Reselo Rubber is a completely renewable material made from birch bark sourced from the residue of the global pulp, paper and plywood industry. The aim of the cooperation agreement now signed is to develop the material further to adapt it for commercial tire production. “According to the initial laboratory tests we have

Nordea Economic Outlook: Precision play

The modest growth that has long characterised the global economy continues. But much indicates that growth will increasingly be driven by Europe. There are prospects of rate cuts in most countries, but the persistently high inflation requires very careful timing and dosage of monetary policy easing, says Helge Pedersen, Nordea Group Chief Economist.The Nordic economies are over the worst. Norway and Denmark have been on solid footing for the past few years, while Sweden and Finland are stabilising after a period with weak economic activity. The Danish economy is growing faster than the

Production of Egoo consumables now established in China to support on-going clinical trials and future sales

Qlife Holding AB (publ) (“Qlife” or the “Company”) recently announced a restructuring and new financing to support its strategic goals. The Company is pleased to report that its operational plan with its partner Hipro Biotechnology (“Hipro”) in China is progressing as planned, with the production of Egoo consumables—EgooCapsule (Biochemistry reagents) and EgooCollect (Blood-to-Plasma filtration)—now established at the partner site. The target is to reach a capacity of 1 million in 2025 and 10 million within 3 years. This production capability will support clinical trial efforts and future

There are no items matching the current filter
There are no more items matching the current filter
Back to top